002390 信邦制药
已收盘 12-12 15:00:00
资讯
新帖
简况
12月12日信邦制药（002390）龙虎榜数据：游资章盟主上榜
证券之星 · 12-12 17:53
12月12日信邦制药（002390）龙虎榜数据：游资章盟主上榜
异动快报：信邦制药（002390）12月12日13点8分触及跌停板
证券之星 · 12-12 13:10
异动快报：信邦制药（002390）12月12日13点8分触及跌停板
信邦制药(002390.SZ)：公司涉嫌单位行贿遭检查机关起诉
智通财经 · 12-10
信邦制药(002390.SZ)：公司涉嫌单位行贿遭检查机关起诉
异动快报：信邦制药（002390）12月10日11点29分触及涨停板
证券之星 · 12-10
异动快报：信邦制药（002390）12月10日11点29分触及涨停板
信邦制药：下属流通公司销售流感药物
证券之星 · 12-05
信邦制药：下属流通公司销售流感药物
信邦制药（002390）2025年三季报简析：净利润同比下降13.74%
证券之星 · 10-30
信邦制药（002390）2025年三季报简析：净利润同比下降13.74%
图解信邦制药三季报：第三季度单季净利润同比下降26.87%
证券之星 · 10-28
图解信邦制药三季报：第三季度单季净利润同比下降26.87%
信邦制药(002390)9月30日股东户数6.43万户，较上期减少3.56%
证券之星 · 10-28
信邦制药(002390)9月30日股东户数6.43万户，较上期减少3.56%
股市必读：信邦制药（002390）10月21日董秘有最新回复
证券之星 · 10-22
股市必读：信邦制药（002390）10月21日董秘有最新回复
异动快报：信邦制药（002390）9月30日10点48分触及涨停板
证券之星 · 09-30
异动快报：信邦制药（002390）9月30日10点48分触及涨停板
股市必读：信邦制药（002390）9月26日董秘有最新回复
证券之星 · 09-29
股市必读：信邦制药（002390）9月26日董秘有最新回复
股市必读：信邦制药（002390）9月22日董秘有最新回复
证券之星 · 09-23
股市必读：信邦制药（002390）9月22日董秘有最新回复
信邦制药：已开发药食同源食品及中药保健用品
证券之星 · 09-22
信邦制药：已开发药食同源食品及中药保健用品
股市必读：信邦制药（002390）9月18日董秘有最新回复
证券之星 · 09-19
股市必读：信邦制药（002390）9月18日董秘有最新回复
信邦制药：大健康产品线上线下结合销售
证券之星 · 09-18
信邦制药：大健康产品线上线下结合销售
信邦制药：中药饮片及大健康产品业务培育成公司新的增长点
证券之星 · 09-03
信邦制药：中药饮片及大健康产品业务培育成公司新的增长点
信邦制药：已形成以白云医院为核心的综合医院体系，设有昏迷促醒中心提供卒中治疗康复方案
市场资讯 · 09-03
信邦制药：已形成以白云医院为核心的综合医院体系，设有昏迷促醒中心提供卒中治疗康复方案
信邦制药将于9月17日召开股东大会，审议修订、制定公司部分治理制度等议案
金融界 · 09-01
信邦制药将于9月17日召开股东大会，审议修订、制定公司部分治理制度等议案
信邦制药(002390.SZ)发布上半年业绩，归母净利润1.07亿元，下降6.69%
智通财经 · 08-29
信邦制药(002390.SZ)发布上半年业绩，归母净利润1.07亿元，下降6.69%
信邦制药：公司持续关注行业政策变化并制定符合发展需求的投资并购策略
证券之星 · 08-19
信邦制药：公司持续关注行业政策变化并制定符合发展需求的投资并购策略
加载更多
公司概况
公司名称：
贵州信邦制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-04-16
主营业务：
贵州信邦制药股份有限公司的主营业务是以医疗服务为核心、辅以医药流通及中医药制造。公司的主要产品是药品、器械、医疗服务、其他产品。
发行价格：
33.00
{"stockData":{"symbol":"002390","market":"SZ","secType":"STK","nameCN":"信邦制药","latestPrice":3.37,"timestamp":1765523037000,"preClose":3.74,"halted":0,"volume":155615961,"delay":0,"changeRate":-0.0989,"floatShares":1928000000,"shares":1944000000,"eps":0.0397,"marketStatus":"已收盘","change":-0.37,"latestTime":"12-12 15:00:00","open":3.51,"high":3.56,"low":3.37,"amount":528000000,"amplitude":0.0508,"askPrice":3.38,"askSize":13544,"bidPrice":3.37,"bidSize":22481,"shortable":0,"etf":0,"ttmEps":0.0397,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":3.74,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":4.11,"lowLimit":3.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1943851868,"isCdr":false,"pbRate":1.08,"roa":"--","peRate":84.88665,"roe":"2.25%","epsLYR":0.05,"committee":0.048163,"marketValue":6551000000,"turnoverRate":0.0807,"status":1,"floatMarketCap":6497000000},"requestUrl":"/m/hq/s/002390","defaultTab":"news","newsList":[{"id":"2590572089","title":"12月12日信邦制药（002390）龙虎榜数据：游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2590572089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590572089?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:53","pubTimestamp":1765533231,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年12月12日公布的交易公开信息显示，信邦制药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月12日收盘，信邦制药报收于3.37元，下跌9.89%，换手率8.07%，成交量155.62万手，成交额5.28亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出803.51万元，北向资金合计净卖出1449.97万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200028821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0004","BK0028","002390","BK0056","BK0239","BK0096","BK0114"],"gpt_icon":0},{"id":"2590252758","title":"异动快报：信邦制药（002390）12月12日13点8分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2590252758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590252758?lang=zh_cn&edition=full","pubTime":"2025-12-12 13:10","pubTimestamp":1765516250,"startTime":"0","endTime":"0","summary":"证券之星12月12日盘中消息，13点8分信邦制药（002390）触及跌停板。其所属行业中药目前下跌。领涨股为金花股份。该股为口腔，体外诊断，基因测序概念热股，当日口腔概念上涨1.58%，体外诊断概念上涨0.05%。12月11日的资金流向数据方面，主力资金净流出1.43亿元，占总成交额24.09%，游资资金净流入6170.6万元，占总成交额10.41%，散户资金净流入8105.12万元，占总成交额13.68%。近5日资金流向一览见下表：信邦制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200017622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0096","BK0056","BK0146","002390","BK0028","BK0114","BK0239"],"gpt_icon":0},{"id":"2590845715","title":"信邦制药(002390.SZ)：公司涉嫌单位行贿遭检查机关起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2590845715","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590845715?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:15","pubTimestamp":1765368911,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信邦制药(002390.SZ)公告，公司近日收到检察机关《审查起诉阶段委托辩护人/申请法律援助告知书》、《犯罪嫌疑人诉讼权利义务告知书》，主要内容为：对公司涉嫌单位行贿一案，检察机关已经收到监察委员会移送起诉的材料。根据《中华人民共和国刑事诉讼法》第三十四条、第三十五条、第二百七十八条之规定，告知公司有权委托辩护人，以及诉讼的权利义务。公告称，本次重大事项对公司的品牌声誉、业务拓展及未来发展可能会产生一定的不利影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"信邦制药(002390.SZ)：公司涉嫌单位行贿遭检查机关起诉","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0004","BK0146","BK0114","BK0056","BK0239","BK0028","BK0096","002390"],"gpt_icon":0},{"id":"2590372614","title":"异动快报：信邦制药（002390）12月10日11点29分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2590372614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590372614?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:30","pubTimestamp":1765337450,"startTime":"0","endTime":"0","summary":"证券之星12月10日盘中消息，11点29分信邦制药触及涨停板。其所属行业中药目前下跌。领涨股为马应龙。该股为医美，土地流转，民营医院概念热股，当日医美概念上涨0.11%，土地流转概念上涨0.06%，民营医院概念上涨0.02%。12月9日的资金流向数据方面，主力资金净流出1979.59万元，占总成交额15.09%，游资资金净流出695.03万元，占总成交额5.3%，散户资金净流入2674.62万元，占总成交额20.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000013614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0004","BK0028","002390","BK0056","BK0239","BK0096","BK0114"],"gpt_icon":0},{"id":"2589014867","title":"信邦制药：下属流通公司销售流感药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2589014867","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589014867?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:33","pubTimestamp":1764923590,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，贵公司在医药流通领域有储备流感药物吗？11月销售情况如何？信邦制药回复：您好，公司下属的医药流通公司销售有您提及的药品，并会根据市场需求进行相应备货。关于公司的经营情况，敬请您关注公司后续披露的定期报告。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500022580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0056","BK0028","BK0114","002390","BK0004","BK0239","BK0146"],"gpt_icon":0},{"id":"2579130415","title":"信邦制药（002390）2025年三季报简析：净利润同比下降13.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579130415","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579130415?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:27","pubTimestamp":1761776833,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期信邦制药发布2025年三季报。根据财报显示，信邦制药净利润同比下降13.74%。截至本报告期末，公司营业总收入42.66亿元，同比下降6.55%，归母净利润1.52亿元，同比下降13.74%。按单季度数据看，第三季度营业总收入14.21亿元，同比下降6.42%，第三季度归母净利润4512.81万元，同比下降26.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000005605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390"],"gpt_icon":0},{"id":"2578995811","title":"图解信邦制药三季报：第三季度单季净利润同比下降26.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578995811","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578995811?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:04","pubTimestamp":1761649498,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药2025年三季报显示，公司主营收入42.66亿元，同比下降6.55%；归母净利润1.52亿元，同比下降13.74%；扣非净利润1.57亿元，同比下降10.5%；其中2025年第三季度，公司单季度主营收入14.21亿元，同比下降6.42%；单季度归母净利润4512.81万元，同比下降26.87%；单季度扣非净利润5021.62万元，同比下降16.84%；负债率18.83%，投资收益26.62万元，财务费用1110.61万元，毛利率17.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800035368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390"],"gpt_icon":0},{"id":"2578939812","title":"信邦制药(002390)9月30日股东户数6.43万户，较上期减少3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939812","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939812?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:33","pubTimestamp":1761643985,"startTime":"0","endTime":"0","summary":"证券之星消息，近日信邦制药披露，截至2025年9月30日公司股东户数为6.43万户，较6月30日减少2375.0户，减幅为3.56%。在中药行业个股中，信邦制药股东户数高于行业平均水平，截至9月30日，中药行业平均股东户数为5.36万户。从股价来看，2025年6月30日至2025年9月30日，信邦制药区间涨幅为10.15%，在此期间股东户数减少2375.0户，减幅为3.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390","BK0096","BK0056","BK0114","BK0004","BK0028","BK0146","BK0239"],"gpt_icon":0},{"id":"2577805687","title":"股市必读：信邦制药（002390）10月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577805687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577805687?lang=zh_cn&edition=full","pubTime":"2025-10-22 02:14","pubTimestamp":1761070469,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，信邦制药报收于3.86元，上涨0.78%，换手率2.58%，成交量49.66万手，成交额1.9亿元。您可凭借持股证明、身份证来公司现场查阅股东名册及相关信息，也可联系公司证券部，工作人员核实股东身份后将予以回复。当日关注点来自交易信息汇总：10月21日主力资金净流出1053.13万元，散户资金净流入1264.77万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200001176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0004","002390","BK0096","BK0114","BK0146","BK0028"],"gpt_icon":0},{"id":"2571999493","title":"异动快报：信邦制药（002390）9月30日10点48分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2571999493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571999493?lang=zh_cn&edition=full","pubTime":"2025-09-30 10:50","pubTimestamp":1759200629,"startTime":"0","endTime":"0","summary":"证券之星9月30日盘中消息，10点48分信邦制药触及涨停板。目前价格3.8，上涨10.14%。其所属行业中药目前下跌。领涨股为万邦德。该股为基因测序，体外诊断，民营医院概念热股，当日基因测序概念上涨0.98%，体外诊断概念上涨0.58%，民营医院概念上涨0.5%。9月29日的资金流向数据方面，主力资金净流入365.01万元，占总成交额5.14%，游资资金净流出48.55万元，占总成交额0.68%，散户资金净流出316.46万元，占总成交额4.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000012382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0056","BK0028","BK0114","BK0004","BK0146","002390","BK0239"],"gpt_icon":0},{"id":"2571297368","title":"股市必读：信邦制药（002390）9月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2571297368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571297368?lang=zh_cn&edition=full","pubTime":"2025-09-29 03:06","pubTimestamp":1759086379,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，信邦制药报收于3.42元，上涨0.0%，换手率0.76%，成交量14.6万手，成交额4995.41万元。董秘最新回复投资者： 董事长目前对企业有什么战略布局！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900001176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0146","BK0004","002390","BK0114","BK0096","BK0028","BK0239"],"gpt_icon":0},{"id":"2569737303","title":"股市必读：信邦制药（002390）9月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2569737303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569737303?lang=zh_cn&edition=full","pubTime":"2025-09-23 03:12","pubTimestamp":1758568337,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，信邦制药报收于3.5元，下跌0.85%，换手率1.33%，成交量25.65万手，成交额8980.5万元。董秘最新回复投资者： 建议公司研发大健康保养营养类中药产品！公司控股子公司贵州同德药业股份有限公司目前已开发了上工同德黄精片、精山饮固体饮料、慧儿高植物固体饮料等药食同源食品以及上工交泰沐足汤、上工香囊、上工本草伴眠枕等中药保健用品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300001960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0146","BK0056","002390","BK0114","BK0028","BK0004","BK0239"],"gpt_icon":0},{"id":"2569659204","title":"信邦制药：已开发药食同源食品及中药保健用品","url":"https://stock-news.laohu8.com/highlight/detail?id=2569659204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569659204?lang=zh_cn&edition=full","pubTime":"2025-09-22 15:54","pubTimestamp":1758527650,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：建议公司研发大健康酒类中药饮品！信邦制药回复：您好，感谢您的建议。公司控股子公司贵州同德药业股份有限公司目前已开发了上工同德黄精片、精山饮固体饮料、慧儿高植物固体饮料等药食同源食品以及上工交泰沐足汤、上工香囊、上工本草伴眠枕等中药保健用品。感谢您对公司的建议和关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200017581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002390","BK0096","BK0056","BK0114","BK0004","BK0028","BK0146","BK0239"],"gpt_icon":0},{"id":"2568407375","title":"股市必读：信邦制药（002390）9月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2568407375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568407375?lang=zh_cn&edition=full","pubTime":"2025-09-19 02:07","pubTimestamp":1758218835,"startTime":"0","endTime":"0","summary":"截至2025年9月18日收盘，信邦制药报收于3.62元，下跌0.55%，换手率2.21%，成交量42.68万手，成交额1.56亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900001319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","002390","BK0028","BK0239","BK0114","BK0146","BK0056","BK0096"],"gpt_icon":0},{"id":"2568449805","title":"信邦制药：大健康产品线上线下结合销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2568449805","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568449805?lang=zh_cn&edition=full","pubTime":"2025-09-18 08:57","pubTimestamp":1758157028,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药(002390)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司拥有苏州省中医院研发团队，手握那么多大健康饮品跟零食类目，为何不进军电商？信邦制药回复：您好，公司控股子公司贵州同德药业股份有限公司的大健康产品业务目前采用线下线上相结合的方式进行销售，线下通过合作代理商进行销售，线上通过公司在淘宝开设的“上工同德企业店”进行销售。公司将持续关注行业发展趋势，并结合公司实际情况，不断完善产品结构，积极探索多渠道营销策略。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800006200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0146","BK0004","002390","BK0231","BK0114","BK0096","BK0028","300959","BK0239"],"gpt_icon":0},{"id":"2564356812","title":"信邦制药：中药饮片及大健康产品业务培育成公司新的增长点","url":"https://stock-news.laohu8.com/highlight/detail?id=2564356812","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564356812?lang=zh_cn&edition=full","pubTime":"2025-09-03 11:34","pubTimestamp":1756870440,"startTime":"0","endTime":"0","summary":"公司目前暂无考虑中药饮片及大健康产品的出口业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300014622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","002390","BK0239","BK0004","BK0056","BK0114","BK0028","BK0096"],"gpt_icon":0},{"id":"2564356557","title":"信邦制药：已形成以白云医院为核心的综合医院体系，设有昏迷促醒中心提供卒中治疗康复方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2564356557","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564356557?lang=zh_cn&edition=full","pubTime":"2025-09-03 11:33","pubTimestamp":1756870430,"startTime":"0","endTime":"0","summary":"有投资者在互动平台向信邦制药提问：“公司有否脑健康战略布局？”","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/03113352885949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0114","BK0146","BK0239","BK0096","BK0004","BK0028","BK0056","002390"],"gpt_icon":0},{"id":"2564475819","title":"信邦制药将于9月17日召开股东大会，审议修订、制定公司部分治理制度等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2564475819","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564475819?lang=zh_cn&edition=full","pubTime":"2025-09-01 18:50","pubTimestamp":1756723812,"startTime":"0","endTime":"0","summary":"信邦制药发布公告，将于2025年9月17日召开第1次临时股东大会，网络投票同日进行。股权登记日为9月11日，当日收市后持有信邦制药股票的投资者可以参与投票。会议地点：贵州省贵阳市乌当区新添大道北段83号科开1号苑15楼会议室。本次股东大会共计审计3项议案，具体如下：1、《2025年半年度利润分配预案》2、《关于取消监事会并修订<公司章程>的议案》3、《关于修订、制定公司部分治理制度的议案》。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/01185052852159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0114","BK0146","BK0239","BK0096","BK0004","BK0028","BK0056","002390"],"gpt_icon":0},{"id":"2563041558","title":"信邦制药(002390.SZ)发布上半年业绩，归母净利润1.07亿元，下降6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563041558","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563041558?lang=zh_cn&edition=full","pubTime":"2025-08-29 18:26","pubTimestamp":1756463167,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信邦制药(002390.SZ)发布2025年半年度报告，该公司营业收入为28.45亿元，同比减少6.62%。归属于上市公司股东的净利润为1.07亿元，同比减少6.69%。归属于上市公司股东的扣除非经常性损益的净利润为1.07亿元，同比减少7.16%。基本每股收益为0.0565元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1338695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002390"],"gpt_icon":0},{"id":"2560191253","title":"信邦制药：公司持续关注行业政策变化并制定符合发展需求的投资并购策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2560191253","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560191253?lang=zh_cn&edition=full","pubTime":"2025-08-19 20:52","pubTimestamp":1755607950,"startTime":"0","endTime":"0","summary":"证券之星消息，信邦制药08月19日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900038180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0004","BK0028","BK0056","BK0146","BK0114","BK0096","002390"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765746952092,"stockEarnings":[{"period":"1week","weight":-0.1425},{"period":"1month","weight":-0.149},{"period":"3month","weight":-0.0739},{"period":"6month","weight":-0.0371},{"period":"1year","weight":-0.2551},{"period":"ytd","weight":-0.2469}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州信邦制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"64321人(较上一季度减少3.56%)","perCapita":"29971股","listingDate":"2010-04-16","address":"贵州省黔南布依族苗族自治州罗甸县龙坪镇信邦大道48号","registeredCapital":"194385万元","survey":" 贵州信邦制药股份有限公司的主营业务是以医疗服务为核心、辅以医药流通及中医药制造。公司的主要产品是药品、器械、医疗服务、其他产品。","listedPrice":33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信邦制药(002390)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信邦制药,002390,信邦制药股票,信邦制药股票老虎,信邦制药股票老虎国际,信邦制药行情,信邦制药股票行情,信邦制药股价,信邦制药股市,信邦制药股票价格,信邦制药股票交易,信邦制药股票购买,信邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信邦制药(002390)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信邦制药(002390)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}